Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer
The Laryngoscope · 2024
DOI: 10.1002/lary.31588 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Rushi Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Cleveland Clinic College of Medicine, Cleveland, Ohio, U.S.A. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Hospitals, High-Volume. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Changing location of postoperative radiotherapy (PORT) after treatment at a high‐volume facility (HVF) is associated with worse survival in various head and neck cancers. Our study investigates this relationship in salivary gland cancer (SGC).
Methods
The 2004–2016 National Cancer Database was queried for all cases of adult SGC treated with surgery and PORT with or without adjuvant chemotherapy. Patients with multiple cancer diagnoses, metastatic disease, or unknown PORT facility were excluded. Reporting facilities with >95th percentile annual case volume were classified as HVFs, the remainder were classified low‐volume facilities (LVFs).
Results
A total of 7885 patients met inclusion criteria, of which 418 (5.3%) were treated at an HVF. Patients treated at an HVF had higher rates clinical nodal positivity (18.2% vs. 14.0%, p < 0.001) and clinical T3/T4 (27.3% vs. 20.7%, p = 0.001) disease. Patients at HVFs changed facility for PORT at lower rates (18.9% vs. 24.5%, p = 0.009). Patients treated at an HVF had higher 5‐year overall survival (5‐OS) than those treated at an LVF (79.0% vs. 72.0%, p = 0.042). Patients treated at an HVF that changed PORT facility had worse 5‐OS (60.8% vs. 83.2%, p < 0.001). Radiation facility change was an independent predictor of worse survival in patients treated at an HVF (HR: 8.99 [3.15–25.67], p < 0.001) but not for patients treated at a LVF (HR: 1.11 [0.98–1.25], p = 0.109).
Conclusions
Patients treated at an HVF changing facility for PORT for SGC experience worse survival. Our data suggest patients treated surgically at an HVF should be counseled to continue their PORT at the same institution. Level of Evidence 3 Laryngoscope , 134:4935–4946, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Cleveland Clinic College of Medicine, Cleveland, Ohio, U.S.A.
- Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, U.S.A.
- Department of Otolaryngology-Head and Neck Surgery, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, U.S.A.
ORCID-Profile: Rushi Patel, Aman M Patel, Christopher C Tseng
Zitieren
APA
Patel, R., Patel, A. M., Revercomb, L., Qie, V., Tseng, C. C., Baredes, S., & Park, R. C. W. (2024). Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer. The Laryngoscope. https://doi.org/10.1002/lary.31588
Vancouver
Patel R, Patel AM, Revercomb L, Qie V, Tseng CC, Baredes S, et al. Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer. The Laryngoscope. 2024. doi:10.1002/lary.31588
BibTeX
@article{Patel2024,
author = {Patel, Rushi and Patel, Aman M and Revercomb, Lucy and Qie, Vivienne and Tseng, Christopher C and Baredes, Soly and Park, Richard Chan Woo},
title = {Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31588}
}
EUVIMED